Literature DB >> 21091361

Exaggerated blood pressure response to exercise--a new portent of masked hypertension.

Mehmet Kayrak1, Ahmet Bacaksiz, Mehmet Akif Vatankulu, Selim S Ayhan, Zeynettin Kaya, Hatem Ari, Osman Sonmez, Hasan Gok.   

Abstract

Masked hypertension (MHT) is a popular entity with increased risk of developing sustained hypertension, heart attack, stroke, and death. Subjects have normal blood pressure (BP) at office but elevated values at night so it is difficult to diagnose. Exaggerated blood pressure response to exercise (EBPR) is also a predictor of future hypertension. To investigate the relationship between these two entities, we evaluated 61 normotensive subjects with EBPR. The subjects underwent 24-h ambulatory blood pressure monitoring (ABPM). The prevalence of masked hypertension among subjects with EBPR was 41%. Body mass index (BMI), non-high density lipoprotein (HDL) cholesterol, diastolic blood pressure (DBP) at peak exercise and recovery, nondipping DBP pattern, and elevated early morning average BPs were associated with masked hypertension. In multivariate logistic regression analysis, the DBP measured at peak exercise was detected as an independent predictor of MHT in subjects with EBPR. Subjects with abnormally elevated BP during exercise are prone to MHT, necessitate medical assessment and close follow-up for hypertension.

Entities:  

Mesh:

Year:  2010        PMID: 21091361     DOI: 10.3109/10641963.2010.503298

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  13 in total

1.  An exaggerated blood pressure response to exercise is associated with nitric oxide bioavailability and inflammatory markers in normotensive females.

Authors:  Ryoma Michishita; Masanori Ohta; Masaharu Ikeda; Ying Jiang; Hiroshi Yamato
Journal:  Hypertens Res       Date:  2016-06-23       Impact factor: 3.872

2.  Exercise Blood Pressure Guidelines: Time to Re-evaluate What is Normal and Exaggerated?

Authors:  Katharine D Currie; John S Floras; Andre La Gerche; Jack M Goodman
Journal:  Sports Med       Date:  2018-08       Impact factor: 11.136

Review 3.  Exercise blood pressure: clinical relevance and correct measurement.

Authors:  J E Sharman; A LaGerche
Journal:  J Hum Hypertens       Date:  2014-10-02       Impact factor: 3.012

Review 4.  Blood Pressure Response to Exercise and Cardiovascular Disease.

Authors:  Martin G Schultz; Andre La Gerche; James E Sharman
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

5.  Exaggerated blood pressure response to exercise is not associated with masked hypertension in patients with high normal blood pressure levels.

Authors:  Alon Grossman; Noa Cohen; Joseph Shemesh; Nira Koren-Morag; Avshalom Leibowitz; Ehud Grossman
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-28       Impact factor: 3.738

6.  Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension.

Authors:  Yuichiro Yano; Anthony J Viera; Alan L Hinderliter; Lana L Watkins; James A Blumenthal; Kristy S Johnson; LaBarron K Hill; Andrew Sherwood
Journal:  Am J Hypertens       Date:  2020-08-04       Impact factor: 3.080

7.  Heart rate recovery and blood pressure response during exercise testing in patients with microvascular angina.

Authors:  Bong-Joon Kim; Eun-Ah Jo; Sung-Il Im; Hyun-Su Kim; Jung Ho Heo; Kyoung-Im Cho
Journal:  Clin Hypertens       Date:  2019-03-01

8.  Relation of serum uric acid to an exaggerated systolic blood pressure response to exercise testing in men with normotension.

Authors:  Sae Young Jae; Kanokwan Bunsawat; Yoon-Ho Choi; Yeon Soo Kim; Rhian M Touyz; Jeong Bae Park; Barry A Franklin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-19       Impact factor: 3.738

Review 9.  Exercise Hypertension.

Authors:  Martin G Schultz; James E Sharman
Journal:  Pulse (Basel)       Date:  2014-04-11

Review 10.  Masked Hypertension: Lessons for the Future.

Authors:  Krishnam R Penmatsa; Mohan Biyani; Ankur Gupta
Journal:  Ulster Med J       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.